more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$82.40 USD

+1.57 (1.94%)

Updated May 14, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.20%
2	Buy	18.04%
3	Hold	9.52%
4	Sell	5.20%
5	Strong Sell	2.60%
S&P	500	11.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum B VGM

Industry Rank:

Bottom 41% (147 out of 250)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Better trading starts here.

Research for MMSI

Annual Key Company Metrics
Quarterly Key Company Metrics

Revenue - Line of Business Segments	YR Estimate	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue: Cardiovascular: Peripher...		502	440	405	342	351
Revenue: Cardiovascular: Cardiac ...		358	343	321	280	305
Revenue: Cardiovascular: Custom P...		195	190	194	203	187
Revenue: Cardiovascular: OEM [$M]		165	145	124	110	118
Revenue: Cardiovascular [$M]		1,221	1,118	1,043	934	961
Revenue: Endoscopy [$M]		37	33	32	30	34
Revenue - Geographic Segments	YR Estimate	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue: Endoscopy: United States...		34	31	29	28	33
Revenue: Endoscopy: International...		2	2	2	2	1
Revenue: Cardiovascular: United S...		727	651	579	522	--
Revenue: Cardiovascular: Interna...		530	500	464	412	--
Geographic Sales: United States [...		727	651	609	550	576
Geographic Sales: International [...		530	500	466	414	419
Revenue: Cardiovascular: Peripher...		299	264	244	212	227
Revenue: Cardiovascular: Peripher...		203	176	161	130	124
Revenue: Cardiovascular: Cardiac ...		144	129	122	108	116
Revenue: Cardiovascular: Cardiac ...		215	214	198	172	189
Revenue: Cardiovascular: Custom P...		114	109	108	110	100
Revenue: Cardiovascular: Custom P...		81	81	86	93	88
Revenue: Cardiovascular: OEM: Uni...		136	119	104	92	101
Revenue: Cardiovascular: OEM: Int...		29	26	19	18	17
Income - Line of Business	YR Estimate	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Operating Income: Cardiovascular ...		114	81	53	-7	26
Operating Income: Endoscopy [$M]		10	7	8	5	-10

Revenue - Line of Business Segments	Qtr Estimate	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023
Revenue: Cardiovascular: Peripher...		135	134	128	126	114
Revenue: Cardiovascular: Cardiac ...		91	90	89	94	85
Revenue: Cardiovascular: Custom P...		49	50	49	49	48
Revenue: Cardiovascular: OEM [$M]		39	41	40	42	41
Revenue: Cardiovascular [$M]		313	315	306	311	288
Revenue: Endoscopy [$M]		10	9	9	9	10
Revenue - Geographic Segments	Qtr Estimate	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023
Revenue: Endoscopy: United States...		10	--	8	8	9
Revenue: Endoscopy: International...		1	--	1	1	1
Revenue: Cardiovascular: United S...		177	--	179	171	162
Revenue: Cardiovascular: Interna...		137	--	127	140	126
Geographic Sales: United States [...		186	--	188	180	171
Geographic Sales: International [...		137	--	128	140	126
Revenue: Cardiovascular: Peripher...		79	--	79	72	69
Revenue: Cardiovascular: Peripher...		55	--	50	54	45
Revenue: Cardiovascular: Cardiac ...		35	--	37	36	34
Revenue: Cardiovascular: Cardiac ...		55	--	53	58	51
Revenue: Cardiovascular: Custom P...		29	--	30	29	27
Revenue: Cardiovascular: Custom P...		20	--	19	20	21
Revenue: Cardiovascular: OEM: Uni...		33	--	34	35	33
Revenue: Cardiovascular: OEM: Int...		7	--	6	8	9
Income - Line of Business	Qtr Estimate	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023
Operating Income: Cardiovascular ...		--	--	33	26	24
Operating Income: Endoscopy [$M]		--	--	3	2	2

Member Sign In

Member Sign In

Services Overview

Investor Services

Other Services

Trading Services

Innovators